Decatur Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Decatur Capital Management's PFE Position: Q3 2023 in Review
Decatur Capital Management sold out of Pfizer (PFE) in Q3 2023, closing a stake of 32,361 shares — an estimated $1.19M sold.
Decatur Capital Management first reported a position in PFE in Q3 2015 and held it in 17 quarters. The position peaked at $19M in Q3 2015. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.
- Decatur Capital Management reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
- Decatur Capital Management sold 32,361 Pfizer shares in Q3 2023, an estimated $1.19M.
- Decatur Capital Management first reported a position in Pfizer in Q3 2015 and held it in 17 quarters.
- Decatur Capital Management's Pfizer position peaked at $19M in Q3 2015.
- 2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.
Based on Decatur Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.